Accessibility Menu

Rbc Life Sciences

(OTC) RBCL

Current Price$0.00
Market Cap$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-100%
5 Year-99%
1 Year+601%
1 Month+17%

Rbc Life Sciences Financials at a Glance

Market Cap

$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$23.60M

Net Income (TTM)

-$690.29K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-13.14 (Low)

Price

$0.00

Volume

150

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 21, 2024

RBCL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rbc Life Sciences

Industry

Personal Products

Headquarters

Irving, TX 75038, US

RBCL Financials

Key Financial Metrics (TTM)

Gross Margin

52.82%

Operating Margin

-2.59%

Net Income Margin

-2.93%

Return on Equity

-10.08%

Return on Capital

-9.34%

Return on Assets

-6.90%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.21M

Volume

150

Avg. Volume

0

Financials (TTM)

Gross Profit

$12.41M

Operating Income

-$789.85K

EBITDA

-$451.87K

Operating Cash Flow

-$349.54K

Capital Expenditure

-$121.84K

Free Cash Flow

-$471.38K

Cash & ST Invst.

$685.43K

Total Debt

$0.00

Rbc Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2017YOY CHG

Revenue

$4.90M

-33.1%

Gross Profit

$2.54M

-35.0%

Gross Margin

51.79%

N/A

Market Cap

$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$17.98

N/A

Employees

89

N/A

Net Income

-$350.41K

-428.6%

EBITDA

-$270.00K

-167.8%

Quarterly Fundamentals

Name
Q3 2017YOY CHG

Total Cash

$685.43K

-47.1%

Total Debt

$0.00

N/A

Accounts Receivable

$1.28M

-17.1%

Inventory

$5.78M

+40.8%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-6.90%

N/A

Return on Invested Capital

-8.78%

N/A

Free Cash Flow

-$92.85K

-116.7%

Operating Cash Flow

-$80.99K

-114.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCGRPC Group, Inc.
$0.00+0.00%
ANFIFAmira Nature Foods Ltd.
$0.00+0.00%
PACVPacific Ventures Group, Inc.
$0.00+0.00%
URBFUrban Barns Foods Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$72.64-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$39.95+0.06%
SKHYSK Hynix
$152.35-0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.27-0.06%

Questions About RBCL

What is the current price of Rbc Life Sciences?

Rbc Life Sciences is trading at $0.00 per share.

What is the 52-week range for Rbc Life Sciences?

Over the past 52 weeks, Rbc Life Sciences has traded between $0.00 and $0.00.

How much debt does Rbc Life Sciences have?

Rbc Life Sciences total debt is unavailable.

How much cash does Rbc Life Sciences have on hand?

Rbc Life Sciences does not have cash on hand data available.

What is Rbc Life Sciences’s dividend yield?

Rbc Life Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.